Skip to contentG
Gilead Sciences, Inc.
G
GILDGilead Sciences, Inc. Q1 2018 · 10-Q
Revenue$5.09B$5.09B−21.8% vs Q1 2017 Net Income$1.54B$1.54B−43.1% vs Q1 2017 EPS Diluted$1.17$1.17−42.9% vs Q1 2017 Gross Profit$4,000,000,000−26.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gilead Sciences, Inc. · CIK 882095 · Engraved from SEC EDGAR
Operating Cash Flow$2,270,000,000−22.4% Free Cash Flowderived$2,058,000,000−26.7% Margins · derivedGross margin78.6%−4.7 pt vs Q1 2017
Operating margin42.3%−15.6 pt vs Q1 2017
Net margin30.2%−11.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end